Today

Agents

Chat

Arena

Discover

More

App

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 common shares for $171.50 - CTTH News | Rallies

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 common shares for $171.50

CTTH•2026-08-31

CEO share purchase

CTT Pharmaceutical Holdings CEO Ryan Khouri bought 3,500 CTTH shares at USD 0.05 each.
Direct holding increased to 9.38 million shares following the purchase.

Related News

Bitdeer AI Announces Sell-Out Of Its 9.5MW A102 Malaysia Data Center

BTDR•2026-08-31

CTS files Form 3 showing VP of Human Resources Heather Pehlke Spitler stake

CTS•2026-08-31

Trump administration announces drug pricing deals with Teva, Astellas and others

XLV•2026-08-31

Sources

S

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 common shares for $171.50

Sec

H

Hershey Trust Co, trustee for Milton Hershey School, sells 20,000 Hershey shares for USD 3.62 million

HSY•2026-08-31

Array Technologies completes acquisition of Affordable Wire Management

ARRY•2026-08-31